Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 294
Selected: 0
NCT IDTitle
NCT00869323Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders
NCT00638820Reduced Intensity AlloTransplant For Osteopetrosis
NCT00006451Bone Marrow Transplantation in Treating Patients With Leukemia
NCT02765997StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies
NCT00309842Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
NCT00652899Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer
NCT03294304BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy
NCT00612716Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
NCT02171104MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
NCT05308316Sugars in Cigarettes
NCT01685411Busulfan and Cyclophosphamide Followed By ALLO BMT
NCT03125642Auto Stem Cell Transplant for Lymphoma Patients
NCT04514029Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel
NCT02145039Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases
NCT05973656Role of Acetaldehyde in the Development of Oral Cancer
NCT00176878Stem Cell Transplant for Bone Marrow Failure Syndromes
NCT00287885Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer
NCT00618540Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis
NCT04928950Charcoal in Lung Cancer Patients Undergoing TEMLA
NCT03152526CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR
NCT00609739Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation
NCT03651037Physical Activity Platform to Improve Bone Health in Cancer Survivors
NCT00726739Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma
NCT02118311Treg Cells for AGVHD in Non-myeloablative UCB Transplant
NCT02693665Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer
NCT00379197Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer
NCT02845414Study of CD133KDEL Toxin in the Treatment for Solid Tumors
NCT01652092Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
NCT04555811FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL
NCT02605421Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
NCT04105270RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
NCT01526603High Dose Chemotherapy and Autologous Transplant for Neuroblastoma
NCT00258427Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia
NCT00276159Study of Immune Response Modifier in the Treatment of Hematologic Malignancies
NCT00357565Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
NCT04003805Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users
NCT01012362Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
NCT00290641Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
NCT00000105Vaccination With Tetanus and KLH to Assess Immune Responses.
NCT00376805Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer
NCT00963872Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer
NCT00643240Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Lymphocytic Leukemia
NCT04858594Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy
NCT00775931Allogeneic Transplantation For Severe Osteopetrosis
NCT04714372FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
NCT02661035Allo HSCT Using RIC for Hematological Diseases
NCT00668564Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
NCT05502302App-Assisted Day Reconstruction to Reduce Logistic Toxicity in Cancer
NCT00617188Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer
NCT02988843Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors